[Corneal ulcer secondary to Pasteurella multocida and Klebsiella oxytoca in a 79-year-old patient with dysthyroid orbitopathy].

Szczegóły

Tytuł:: [Corneal ulcer secondary to Pasteurella multocida and Klebsiella oxytoca in a 79-year-old patient with dysthyroid orbitopathy].
Autorzy:: Cornée C; Service d'ophtalmologie, centre hospitalo-universitaire de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France. Electronic address: .
Mainguy A; Service d'ophtalmologie, centre hospitalo-universitaire de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Coeuru D; Service d'ophtalmologie, centre hospitalo-universitaire de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Routier M; Service d'ophtalmologie, centre hospitalo-universitaire de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Lebranchu P; Service d'ophtalmologie, centre hospitalo-universitaire de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Vabres B; Service d'ophtalmologie, centre hospitalo-universitaire de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.
Transliterated Title:: Abcès cornéen à Pasteurella multocida et à Klebsiella oxytoca chez une patiente de 79 ans présentant une orbitopathie dysthyroïdienne.
Źródło:: Journal francais d'ophtalmologie [J Fr Ophtalmol] 2020 Sep; Vol. 43 (7), pp. e245-e246. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji:: Case Reports; Letter
Język:: French
Imprint Name(s):: Original Publication: Paris, New York, Masson.
MeSH Terms:: Corneal Ulcer/*diagnosis
Corneal Ulcer/*microbiology
Eye Infections, Bacterial/*diagnosis
Graves Ophthalmopathy/*complications
Klebsiella oxytoca/*isolation & purification
Pasteurella multocida/*isolation & purification
Aged ; Amnion/transplantation ; Anti-Bacterial Agents/administration & dosage ; Ceftazidime/administration & dosage ; Ciprofloxacin/administration & dosage ; Coinfection/complications ; Coinfection/diagnosis ; Coinfection/microbiology ; Combined Modality Therapy ; Corneal Ulcer/complications ; Corneal Ulcer/therapy ; Drug Resistance, Bacterial/drug effects ; Drug Therapy, Combination ; Eye Infections, Bacterial/complications ; Eye Infections, Bacterial/microbiology ; Eye Infections, Bacterial/therapy ; Female ; Graves Ophthalmopathy/diagnosis ; Graves Ophthalmopathy/microbiology ; Graves Ophthalmopathy/therapy ; Humans ; Klebsiella Infections/complications ; Klebsiella Infections/diagnosis ; Klebsiella Infections/microbiology ; Klebsiella Infections/therapy ; Pasteurella Infections/complications ; Pasteurella Infections/diagnosis ; Pasteurella Infections/microbiology ; Pasteurella Infections/therapy
Substance Nomenclature:: 0 (Anti-Bacterial Agents)
5E8K9I0O4U (Ciprofloxacin)
9M416Z9QNR (Ceftazidime)
Entry Date(s):: Date Created: 20200623 Date Completed: 20201022 Latest Revision: 20201022
Update Code:: 20240105
DOI:: 10.1016/j.jfo.2019.10.021
PMID:: 32564980
: Raport

Informacja